Iso 13485 - 2016
Iso 13485 - 2016
Iso 13485 - 2016
7.2.3 Communication
The organization shall plan and document arrangements for communicating with customers in
relation to:
a) product information;
b) enquiries, contracts or order handling, including amendments;
c) customer feedback, including complaints;
d) advisory notices.
The organization shall communicate with regulatory authorities in accordance with applicable
regulatory requirements.
7.3.1 General
The organization shall plan and control the design and development of product. As appropriate, design
and development planning documents shall be maintained and updated as the design and development
progresses.
During design and development planning, the organization shall document:
a) the design and development stages;
b) the review(s) needed at each design and development stage;
c) the verification, validation, and design transfer activities that are appropriate at each design and
development stage;
d) the responsibilities and authorities for design and development;
e) the methods to ensure traceability of design and development outputs to design and
development inputs;
f) the resources needed, including necessary competence of personnel.
Inputs relating to product requirements shall be determined and records maintained (see 4.2.5). These
inputs shall include:
a) functional, performance, usability and safety requirements, according to the intended use;
b) applicable regulatory requirements and standards;
c) applicable output(s) of risk management;
d) as appropriate, information derived from previous similar designs;
e) other requirements essential for design and development of the product and processes.
These inputs shall be reviewed for adequacy and approved.
Requirements shall be complete, unambiguous, able to be verified or validated, and not in conflict with
each other.
NOTE Further information can be found in IEC 62366–1.
At suitable stages, systematic reviews of design and development shall be performed in accordance
with planned and documented arrangements to:
a) evaluate the ability of the results of design and development to meet requirements;
b) identify and propose necessary actions.
Participants in such reviews shall include representatives of functions concerned with the design and
development stage being reviewed, as well as other specialist personnel.
Records of the results of the reviews and any necessary actions shall be maintained and include the
identification of the design under review, the participants involved and the date of the review (see 4.2.5).
Design and development verification shall be performed in accordance with planned and documented
arrangements to ensure that the design and development outputs have met the design and development
input requirements.
The organization shall document verification plans that include methods, acceptance criteria and, as
appropriate, statistical techniques with rationale for sample size.
If the intended use requires that the medical device be connected to, or have an interface with, other
medical device(s), verification shall include confirmation that the design outputs meet design inputs
when so connected or interfaced.
Records of the results and conclusions of the verification and necessary actions shall be maintained
(see 4.2.4 and 4.2.5).
Design and development validation shall be performed in accordance with planned and documented
arrangements to ensure that the resulting product is capable of meeting the requirements for the
specified application or intended use.
The organization shall document validation plans that include methods, acceptance criteria and, as
appropriate, statistical techniques with rationale for sample size.
The organization shall document procedures for transfer of design and development outputs to
manufacturing. These procedures shall ensure that design and development outputs are verified
as suitable for manufacturing before becoming final production specifications and that production
capability can meet product requirements.
Results and conclusions of the transfer shall be recorded (see 4.2.5).
The organization shall document procedures to control design and development changes. The
organization shall determine the significance of the change to function, performance, usability, safety
and applicable regulatory requirements for the medical device and its intended use.
Design and development changes shall be identified. Before implementation, the changes shall be:
a) reviewed;
b) verified;
c) validated, as appropriate;
d) approved.
The review of design and development changes shall include evaluation of the effect of the changes on
constituent parts and product in process or already delivered, inputs or outputs of risk management
and product realization processes.
Records of changes, their review and any necessary actions shall be maintained (see 4.2.5).
The organization shall maintain a design and development file for each medical device type or medical
device family. This file shall include or reference records generated to demonstrate conformity to the
requirements for design and development and records for design and development changes.